The first, tristetraprolin (also known as ZFP36) is upregulated transcriptionally during iron deficiency to specifically reduce the stability of mRNAs for iron-dependent proteins in the electron transport chain, consequently driving a shift from oxidative phosphorylation to glycolysis to conserve iron [3, 4]. Here, ZFP36 is linked to nutritional disorder.